Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 3, 2025 • 4:51 PM ET

Date/Time Source News Release
12/17/2024 07:00 AM EST GlobeNewswire Tiziana Life Sciences Announces First Patient with Moderate Alzheimer's Disease Dosed with Intranasal Foralumab
12/04/2024 07:00 AM EST GlobeNewswire Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers
11/19/2024 07:00 AM EST GlobeNewswire Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
11/01/2024 01:00 PM EDT GlobeNewswire Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data
10/30/2024 10:29 PM EDT GlobeNewswire Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million
10/30/2024 08:30 AM EDT GlobeNewswire Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study
09/19/2024 07:00 AM EDT GlobeNewswire Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer's Disease
08/19/2024 07:00 AM EDT GlobeNewswire Tiziana Life Sciences Appoints New Chief Executive Officer
08/14/2024 07:00 AM EDT GlobeNewswire Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
07/24/2024 07:00 AM EDT GlobeNewswire Tiziana Life Sciences Granted FDA Fast Track Designation
Page

Additional News

As of January 3, 2025 • 4:51 PM ET

Date/Time Source News Release
12/24/2024 10:59 AM EST SeekingAlpha Tiziana Life Sciences: Awaiting Data Of Foralumab For Secondary Progressive Multiple Sclerosis
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Tiziana Life Sciences Ltd
09/18/2024 02:08 PM EDT SeekingAlpha Tesla's upcoming robotaxi event has analysts and investors guessing
08/19/2024 07:54 AM EDT SeekingAlpha Tiziana Life Sciences appoints Elrifi as CEO
08/14/2024 07:16 AM EDT SeekingAlpha Tiziana Life Sciences regains compliance with Nasdaq
07/24/2024 09:08 AM EDT SeekingAlpha Tiziana spikes on FDA fast track tag for lead asset
06/28/2024 04:10 PM EDT SeekingAlpha Tiziana announces $3.4M non-dilutive funding
06/28/2024 07:53 AM EDT News Direct Tiziana Life Sciences adds to treasury with $3.4 million in non-dilutive funding
06/11/2024 08:45 AM EDT Financial News Media Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
06/11/2024 08:39 AM EDT SeekingAlpha Tiziana multiple sclerosis asset foralumab Fast Track application accepted
Page